GNCA stock fell to $0.0001 on NASDAQ during intraday trade on 12 Mar 2026, marking one of the session’s top losers. The share fell roughly -97.44% from the prior close on very low volume of 30,268 shares. Traders cite thin liquidity and a prior Chapter 11 filing as context for the abrupt move, while average volume sits near 80,568 shares. We look at the price action, balance sheet metrics, risks, and a short-term forecast for GNCA stock to help investors parse today’s sell-off.
GNCA stock intraday price action
GNCA stock traded between $0.0001 and $0.0001 today after opening at $0.0007, according to intraday prints on NASDAQ. The reported change was -0.0038 in absolute terms and -97.44% in percentage terms versus the previous close of $0.0039. Volume of 30,268 shares equals a relative volume of about 0.38 compared with an average of 80,568. The combination of an extremely low price and thin turnover amplified the percentage move.
GNCA stock financials and key metrics
On fundamentals, Genocea shows cash per share $0.54 and book value per share $0.39 on the latest TTM data, which gives some working capital cushion. Revenue per share is $0.02 while net income per share is -0.22, reflecting ongoing losses. The current ratio is 2.24 and interest coverage is high at 46.47, but market capitalization is reported as 0 and shares outstanding are not disclosed, which complicates valuation. Price averages show a 50-day at $0.004724 and 200-day at $0.114619, indicating a long downtrend.
GNCA stock Chapter 11 context and recent news
Genocea filed a Chapter 11 petition in July 2022, a fact that still shapes investor sentiment and liquidity. Limited recent coverage and fewer active market makers have reduced visible order depth. For comparison and screening data, see the market overview and peer comparison on Investing.com source. Company details are available at the Genocea website source.
Meyka AI rates GNCA with a score out of 100
Meyka AI rates GNCA with a score out of 100: 62.67 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector and industry comparisons, financial growth, key metrics, forecasts, analyst consensus, and fundamental growth. The grade reflects balance sheet pockets of cash against severe price decline and low liquidity. These grades are not guaranteed and we are not financial advisors.
Risks, liquidity and GNCA stock trading cautions
Key risks include near-zero quoted price, unknown float, minimal visible market cap, and a small average daily volume of 80,568 shares. The year high was $1.45 and the year low is $0.0001, highlighting extreme volatility. Trading GNCA stock exposes investors to wide spreads, execution risk, and potential regulatory or corporate restructuring outcomes.
Meyka outlook and GNCA stock price targets
Meyka AI’s forecast model projects a 12-month baseline target of $0.001 for GNCA stock, which implies an upside of +900.00% versus the last trade at $0.0001. We also model a conservative scenario near $0.0001 (flat) and a downside case that would see continued depreciation. Forecasts are model-based projections and not guarantees. Analysts should treat targets as scenario-based guidance given the stock’s illiquidity and restructuring history.
Final Thoughts
GNCA stock is trading as an intraday top loser on NASDAQ on 12 Mar 2026, with the last print at $0.0001 and a one-day decline near -97.44%. The price action reflects very low liquidity, a history of Chapter 11 proceedings, and limited recent market coverage. Financial metrics show cash per share $0.54 and a current ratio 2.24, which provide a modest balance sheet buffer but do not offset trading and restructuring risks. Meyka AI’s forecast model projects a 12-month baseline target of $0.001, implying +900.00% upside from the last trade; this is a model output, not a recommendation. Given unknown float, zero reported market cap, and sparse liquidity, GNCA stock is best treated as speculative and high risk. For active traders we recommend strict position sizing, limit orders, and cross-checking filings and exchange notices. Use Meyka AI’s real-time tools for updates and deeper screening before considering any exposure.
FAQs
Why did GNCA stock drop so sharply intraday?
The steep intraday drop in GNCA stock reflects thin liquidity, low visible market cap, and residual concerns from a prior Chapter 11 filing. Small volumes can create outsized percentage moves when a few orders hit the tape.
What are the main financial supports for GNCA stock?
Genocea reports cash per share $0.54 and a current ratio 2.24, which provide short-term liquidity. However, ongoing losses and limited revenue mean cash runway and restructuring outcomes drive value more than operating metrics.
What does Meyka AI forecast for GNCA stock?
Meyka AI’s forecast model projects a 12-month baseline price of $0.001, implying +900.00% from the last trade at $0.0001. Forecasts are model-based and not guarantees.
Is GNCA stock suitable for long-term portfolios?
GNCA stock is high risk and illiquid, making it inappropriate for most long-term, diversified portfolios. Only experienced investors who can accept potential total loss and conduct deep due diligence should consider exposure.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)